MRNA VACCINES AND THE FUTURE OF IMMUNIZATION IN CHRONIC AND DEGENERATIVE DISEASES
DOI:
https://doi.org/10.63330/aurumpub.049-052Keywords:
Chronic diseases, Immunization, Personalized medicine, mRNA technology, mRNA vaccinesAbstract
Messenger RNA (mRNA) vaccines represent one of the most important biotechnological innovations in modern immunization, expanding therapeutic possibilities beyond the control of infectious diseases. This study aimed to analyze the potential of mRNA vaccines in the prevention and treatment of chronic and degenerative diseases, highlighting their applications, challenges, and future perspectives. The methodology consisted of a narrative review of scientific literature based on articles indexed in national and international databases published in recent years, including studies related to immunology, biotechnology, and advanced therapies. The results demonstrated that mRNA technology has a high capacity to induce specific immune responses, flexibility in vaccine platform development, and potential applications in diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions. Recent studies have shown important advances in therapeutic vaccines focused on immunomodulation and personalized medicine. However, challenges remain regarding molecular stability, production costs, and large-scale distribution. It is concluded that mRNA vaccines have significant potential to transform prevention and treatment strategies, representing a promising tool for the future of immunization in chronic and degenerative diseases.
Downloads
References
GIL, Antonio Carlos. Métodos e técnicas de pesquisa social. 7. ed. São Paulo: Atlas, 2019.
KARIKÓ, Katalin; BUCKSTEIN, Martin; NI, Houping; WEISSMAN, Drew. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity, Cambridge, v. 23, n. 2, p. 165–175, 2005.
LAKATOS, Eva Maria; MARCONI, Marina de Andrade. Fundamentos de metodologia científica. 9. ed. São Paulo: Atlas, 2021.
PARDI, Norbert; HOGAN, Michael J.; PORTER, Frederick W.; WEISSMAN, Drew. mRNA vaccines: a new era in vaccinology. Nature Reviews Drug Discovery, Londres, v. 17, n. 4, p. 261–279, 2018.
POLACK, Fernando P.; THOMAS, Stephen J.; KITCHIN, Nicholas et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. The New England Journal of Medicine, Boston, v. 383, n. 27, p. 2603–2615, 2020.
SAHIN, Ugur; KARIKÓ, Katalin; TÜRECI, Özlem. mRNA-based therapeutics: developing a new class of drugs. Nature Reviews Drug Discovery, Londres, v. 13, n. 10, p. 759–780, 2014.
SEVERINO, Antônio Joaquim. Metodologia do trabalho científico. 24. ed. São Paulo: Cortez, 2017.
ZHANG, Cheng; MARUGGI, Giuliana; SHAN, Hongbing; LI, Jun. Advances in mRNA vaccines for infectious diseases. Frontiers in Immunology, Lausanne, v. 10, p. 594, 2019.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
